gold has been researched along with dasatinib in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Asmussen, J; Craik, CS; Jun, YW; Seo, D; Shah, N; Tajon, CA | 1 |
| Gordon, DJ; Gordon, PM; Gossai, NP; Li, NS; Naumann, JA; Piccirilli, JA; Zamora, EA | 1 |
| Adena, SKR; Mishra, B; Upadhyay, M; Vardhan, H | 2 |
| Huang, X; Ren, J; Yi, F | 1 |
| Akbari, V; Haghiralsadat, F; Khorshid, M; Khorshid, P; Rostami, M; Varshosaz, J | 1 |
6 other study(ies) available for gold and dasatinib
| Article | Year |
|---|---|
Sensitive and selective plasmon ruler nanosensors for monitoring the apoptotic drug response in leukemia.
Topics: Apoptosis; Caspase 3; Dasatinib; Enzyme Assays; Gold; Humans; K562 Cells; Leukemia; Nanoparticles; Nanotechnology; Proteomics; Pyrimidines; Silicon Dioxide; Thiazoles | 2014 |
Drug conjugated nanoparticles activated by cancer cell specific mRNA.
Topics: 3T3 Cells; Animals; Antineoplastic Agents; Cell Line, Tumor; Dasatinib; Drug Carriers; Gold; HEK293 Cells; Humans; K562 Cells; Metal Nanoparticles; Mice; Neoplasms; RNA, Messenger; Xenograft Model Antitumor Assays | 2016 |
Development, optimization, and in vitro characterization of dasatinib-loaded PEG functionalized chitosan capped gold nanoparticles using Box-Behnken experimental design.
Topics: Chemistry, Pharmaceutical; Chitosan; Dasatinib; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Drug Liberation; Gold; Metal Nanoparticles; Particle Size; Polyethylene Glycols; Research Design | 2018 |
Simple and Sensitive Method for Determination of Protein Kinase Activity Based on Surface Charge Change of Peptide-Modified Gold Nanoparticles As Substrates.
Topics: Biosensing Techniques; Dasatinib; Drug Evaluation, Preclinical; Enzyme Assays; Gold; Humans; K562 Cells; Limit of Detection; Metal Nanoparticles; Peptides; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-abl; Static Electricity; Surface Properties | 2018 |
Gold nanoparticles for sustained antileukemia drug release: development, optimization and evaluation by quality-by-design approach.
Topics: Animals; Antineoplastic Agents; Biocompatible Materials; Biological Availability; Cell Survival; Dasatinib; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Liberation; Drug Stability; Female; Gold; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Metal Nanoparticles; Particle Size; Rats, Sprague-Dawley; Risk Assessment; Surface Properties | 2019 |
Anti HER-2 aptamer functionalized gold nanoparticles of dasatinib for targeted chemo-radiotherapy in breast cancer cells.
Topics: Aptamers, Nucleotide; Breast Neoplasms; Chemoradiotherapy; Dasatinib; Female; Gold; Humans; Metal Nanoparticles | 2023 |